Why the study?
Does CAPD improve left ventricular anatomy and function in patients with end-stage renal disease and left ventricular hypertrophy?
Does CAPD improve left ventricular anatomy and function in patients with end-stage renal disease and left ventricular hypertrophy?
CAPD improves left ventricular hypertrophy and function in patients with end-stage renal disease by normalizing pressure and volume overload.
May support CAPD for LV remodeling in ESRD; leaves open confirmation in controlled trials before practice change.
In 17 patients with end-stage renal disease, we evaluated the effects of treatment with CAPD on L V anatomy and function by M -mode echocardiography. All patients had a history of hypertension and had echocardiographic evidence of increased LV mass related to both concentric and eccentric hypertrophy. On CAPD, blood pressure returned to normal in a consistent manner. L V mass decreased in most (14/17) patients as a result of a decrease in both L V wall thickness and LV dimension. Initially four of the 17 patients had diminished LV function. On CAPD, LV function improved in three of these four and no patient showed deterioration. These results indicate that CAPD improves L V hypertrophy and L V function by normalizing both pressure and volume overload.
No takes yet. Share an insight, caveat, or question.
Leenen et al. (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: